Cutler Group LP
- SEC CIK
- 0001534270
- Latest filing
- Apr 19, 2024
SAGE holding history
Sage Therapeutics, Inc. in every 13F filed by Cutler Group LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SAGE overviewAll 13F holders of SAGEFull Q1 2024 holdings
- Shares (Q1 2024)
- 200
- Value
- $3.00K
- % of portfolio
- <0.1%
- Quarters held
- 11
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 200 | $3.00K | <0.1% | +200 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −8,080−100.0% | Sold out | Holders |
| Q2 2023 | 8,080 | $379.0K | 0.1% | +180+2.3% | Added | Holders |
| Q1 2023 | 7,900 | $331.0K | 0.1% | −300−3.7% | Reduced | Holders |
| Q4 2022 | 8,200 | $312.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 8,200 | $321.0K | <0.1% | −170−2.0% | Reduced | Holders |
| Q2 2022 | 8,370 | $270.0K | <0.1% | −2,065−19.8% | Reduced | Holders |
| Q1 2022 | 10,435 | $345.0K | <0.1% | +2,835+37.3% | Added | Holders |
| Q4 2021 | 7,600 | $323.0K | <0.1% | +720+10.5% | Added | Holders |
| Q3 2021 | 6,880 | $304.0K | <0.1% | +5,040+273.9% | Added | Holders |
| Q2 2021 | 1,840 | $104.0K | <0.1% | −2,086−53.1% | Reduced | Holders |
| Q1 2021 | 3,926 | $293.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.